Theranautilus, a deep-tech startup pioneering nanorobotic healthcare solutions, has raised $1.2 million in a seed funding round led by pi Ventures. The round also saw participation from Golden Sparrow Ventures and notable angel investors, including Abhishek Goyal, founder and CEO of Tracxn, and Lalit Keshre, CEO of Groww.
The Bengaluru-based company plans to utilize the funds to commercialize its nanorobotics-based medical devices, focusing initially on dental care applications. In addition, Theranautilus will use the capital to refine its go-to-market strategy and expand its technological innovations to address broader healthcare challenges beyond dentistry.
A Precision Solution for Dental Health
Founded in 2020 by Ambarish Ghosh, Debayan Dasgupta, and Peddi Shanmukh Srinivas, Theranautilus is tackling dental health issues like hypersensitivity, a condition affecting over two billion people globally. The company’s patented nanorobotic platform delivers targeted solutions by deploying precision-engineered nanorobots into dental tissues. These nanorobots deliver biocompatible materials that can be externally triggered to form bio-mimetic structures, effectively repairing damaged tissues and offering long-term relief.
This cutting-edge solution addresses a significant need in the $6 billion dental hypersensitivity market and has the potential to disrupt traditional treatments with its targeted and durable approach.
Expanding Beyond Dental Care
While its initial focus is on dental health, Theranautilus has broader ambitions. Leveraging its international patents and proprietary nanotechnology, the company plans to develop precision theranostics for managing cancer therapies and treating other complex diseases.
The company’s innovative approach represents a significant leap in nanorobotics, positioning Theranautilus as a transformative force in both dentistry and broader healthcare sectors.
